10 Februar 2013

Grovepoint buys control of Algatechnologies at $50m company value

The UK equity firm bought control of the Kibbutz Ketura start up, which cultivates microalgae to supply a powerful antioxidant

British private equity firm Grovepoint Capital has acquired control of biotechnology company Algatechnologies Ltd. at a value of $50 million. Founded by Kibbutz Ketura in 1998, Algatechnologies commercially cultivates the microalgae Haematococcus pluvialis to supply a powerful antioxidant – astaxanthin.

Algatechnologies was founded on the basis of research by Prof. Sammy Boussiba at Ben Gurion University of the Negev Landau Family Microalgal Biotechnology Laboratory, and the company is run by chairman Ed Hofland and CEO Hagay Tzur. The company’s shareholders are Kibbutz Ketura and the Jewish Colonization Association.

…Full text: www.globes.co.il/serveen/globes/docview.asp?did=1000820990&fid=1725

Tags: AstaPure, pharmaceuticals, Israel, microalgae-based biological substances, agriculture, food , water, energy, cleantech

Source: Globes, 2013-02-10.

Supplier

Share on Twitter+1Share on FacebookShare on XingShare on LinkedInShare via email